Ericlear Cream contains Eberconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin. It exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and certain Gram-positive bacteria by inhibiting the biosynthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Ericlear Cream is effective in managing conditions such as tinea corporis, tinea cruris, tinea pedis, and candidiasis of the skin. The cream formulation ensures enhanced skin penetration and sustained antifungal action. It is generally well tolerated, with minimal adverse effects; however, mild local irritation, burning sensation, or erythema may occasionally occur at the application site. Ericlear Cream should be applied topically to the affected area once or twice daily, as directed by a healthcare professional, typically for a duration of 2 to 4 weeks depending on the severity and type of infection. Patients are advised to avoid contact with eyes and mucous membranes and to discontinue use if hypersensitivity reactions develop. Proper hygiene and adherence to the prescribed treatment regimen are essential to prevent recurrence and ensure optimal therapeutic outcomes.